Exhibit 5.1

|
+1 617 526 6000 (t) +1 617 526 5000 (f) wilmerhale.com |
December 9, 2020
Curis, Inc.
128 Spring Street, Building C – Suite 500
Lexington, Massachusetts 02421
Re: Prospectus Supplement to Registration Statement on Form S-3
Ladies and Gentlemen:
This opinion is furnished to you in connection with (i) the Registration Statement on Form S-3 (File No. 333-224627) (the “Registration Statement”) filed by Curis, Inc., a Delaware corporation (the “Company”), with the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “Securities Act”), for the registration of, among other things, shares of the Company’s common stock, $0.01 par value per share (the “Common Stock”), which may be issued from time to time on a delayed or continuous basis pursuant to Rule 415 under the Securities Act at an aggregate initial offering price not to exceed $200,000,000, as set forth in the Registration Statement and the prospectus contained therein regarding the offering, issuance and sale of up to $200,000,000 of the Company’s common stock, preferred stock and warrants (the “Base Prospectus”) and any amendments or supplements thereto; (ii) the preliminary prospectus supplement, dated December 8, 2020 (the “Preliminary Prospectus Supplement”); and (iii) the prospectus supplement, dated December 9, 2020 (the “Prospectus Supplement” and, together with the Preliminary Prospectus Supplement and the Base Prospectus, the “Prospectuses”) relating to the issuance and sale pursuant to the Registration Statement of up to 29,500,000 shares of Common Stock (the “Shares”), including up to 3,847,826 shares of Common Stock issuable upon exercise of an option to purchase additional shares granted by the Company.
The Shares are to be issued and sold by the Company pursuant to an underwriting agreement dated December 9, 2020 (the “Underwriting Agreement”), among the Company and Cantor Fitzgerald & Co., acting as representative of the underwriters named therein, the form of which is being filed with the Commission as Exhibit 1.1 to the Company’s Current Report on Form 8-K, to be filed on the date hereof.
We are acting as counsel for the Company in connection with the issue and sale by the Company of the Shares. We have examined a signed copy of the Registration Statement and copies of the Prospectuses, each as filed with the Commission. We have also examined and relied upon the Underwriting Agreement, minutes of meetings of the stockholders and the Board of Directors of the Company, including committees thereof, as provided to us by the Company, the Certificate of Incorporation and By-Laws of the Company, each as restated and/or amended to date, and such other documents as we have deemed necessary for purposes of rendering the opinions hereinafter set forth.
